Profiel
Dr. Horacio Plotkin, MD, is Chief Medical Officer at Retrophin, Inc.
He received his doctorate degree from Universidad de Buenos Aires.
Eerdere bekende functies van Horacio Plotkin
| Bedrijven | Functie | Einde |
|---|---|---|
| CARTESIAN THERAPEUTICS, INC. | Corporate Officer/Principal | 01-03-2020 |
| TRAVERE THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 01-02-2016 |
Opleiding van Horacio Plotkin
| Universidad de Buenos Aires | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| TRAVERE THERAPEUTICS, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Selecta Biosciences, Inc.
 Selecta Biosciences, Inc. BiotechnologyHealth Technology Selecta Biosciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the research and development of nanoparticle immunomodulatory drugs for the treatment and prevention of human diseases. Its portfolio includes pipeline, autoimmune, gene therapy, and biologic therapy. The company was founded by Omid C. Farokhzad, Robert S. Langer Jr., and Ulrich von Andrian on December 10, 2007 and is headquartered in Watertown, MA. | Health Technology |
